106 related articles for article (PubMed ID: 15867164)
1. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke.
Mann J
Stroke; 2005 May; 36(5):929; author reply 929. PubMed ID: 15867164
[No Abstract] [Full Text] [Related]
2. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
Frank JI
Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
[No Abstract] [Full Text] [Related]
3. Eligibility and rate of treatment for recombinant tissue plasminogen activator in acute ischemic stroke using different criteria.
Huang P; Khor GT; Chen CH; Lin RT; Liu CK
Acad Emerg Med; 2011 Mar; 18(3):273-8. PubMed ID: 21401790
[TBL] [Abstract][Full Text] [Related]
4. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerated dosing regimen.
Coplin WM; Broderick J; Tomsick TT
Neurosurgery; 2001 Jul; 49(1):228-9. PubMed ID: 11440452
[No Abstract] [Full Text] [Related]
5. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
Hsieh HC; Chen CH
Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
[No Abstract] [Full Text] [Related]
6. [Management of acute ischemic stroke].
Minematsu K
No To Shinkei; 2004 Nov; 56(11):921-6. PubMed ID: 15678948
[No Abstract] [Full Text] [Related]
7. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
8. Intravenous thrombolysis in stroke patients taking novel oral anticoagulants: experience with the low-dose 0.6 mg/kg of recombinant tissue-type plasminogen activator. Case reports.
Plastino M; Bosco D; Giofrè L; Cristiano D; Galati F; Postorino P; Consoli A; Fava A; Consoli D
J Neurol Sci; 2018 Oct; 393():24-26. PubMed ID: 30098500
[No Abstract] [Full Text] [Related]
9. New treatments for acute ischemic stroke.
Ferguson JJ
Circulation; 1996 May; 93(9):1604. PubMed ID: 8653859
[No Abstract] [Full Text] [Related]
10. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?
Kent DM; Ruthazer R; Selker HP
Stroke; 2003 Feb; 34(2):464-7. PubMed ID: 12574561
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke.
Qureshi AI; Ali Z; Suri MF; Kim SH; Shatla AA; Ringer AJ; Lopes DK; Guterman LR; Hopkins LN
Neurosurgery; 2001 Jul; 49(1):41-8; discussion 48-50. PubMed ID: 11440458
[TBL] [Abstract][Full Text] [Related]
12. Recombinant tissue plasminogen activator: in my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability?
Wyer PC; Osborn HH
Ann Emerg Med; 1997 Nov; 30(5):629-38. PubMed ID: 9360575
[No Abstract] [Full Text] [Related]
13. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.
Haley EC; Brott TG; Sheppard GL; Barsan W; Broderick J; Marler JR; Kongable GL; Spilker J; Massey S; Hansen CA
Stroke; 1993 Jul; 24(7):1000-4. PubMed ID: 8322373
[TBL] [Abstract][Full Text] [Related]
14. Medicine. Stroke--tPA and the clinic.
Marler JR; Goldstein LB
Science; 2003 Sep; 301(5640):1677. PubMed ID: 14500967
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis in acute ischemic stroke.
Hicks P
J Am Board Fam Pract; 1998; 11(5):422-3. PubMed ID: 9796775
[No Abstract] [Full Text] [Related]
16. The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke.
Buijs JE; Uyttenboogaart M; Brouns R; de Keyser J; Kamphuisen PW; Luijckx GJ
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):312-6. PubMed ID: 26527412
[TBL] [Abstract][Full Text] [Related]
17. [Recombinant tissue plasminogen activator therapy for acute ischemic stroke in older patients].
Arai N; Deguchi I; Hayashi T; Tanahashi N; Takao M
Nihon Ronen Igakkai Zasshi; 2018; 55(4):632-639. PubMed ID: 30542029
[TBL] [Abstract][Full Text] [Related]
18. Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke.
Campello E; Farina F; Spiezia L; Maggiolo S; Palmieri A; Sartorello F; Baracchini C; Simioni P
Thromb Haemost; 2016 Jun; 115(6):1231-4. PubMed ID: 26864700
[No Abstract] [Full Text] [Related]
19. Does "time is brain" also mean "time is clot"? Time dependency of tissue-type plasminogen activator-induced recanalization in acute ischemic stroke.
Tsivgoulis G; Alexandrov AV
Stroke; 2014 Sep; 45(9):2555-6. PubMed ID: 25104843
[No Abstract] [Full Text] [Related]
20. Physician knowledge of the benefits, risks, and contraindications of tissue plasminogen activator for acute ischemic stroke.
Merino JG; Silver B; Wong E; Demaerschalk B; Tamayo A; Hachinski V
Stroke; 2001 Sep; 32(9):2208-9. PubMed ID: 11546923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
